Study Design of Immunotherapy of Ragweed Allergy

William Franklin; W. J. Metzger; R. Patterson; J. J. Pruzansky; C. R. Zeiss; Philip S. Norman; Lawrence M. Lichtenstein

doi:10.1056/NEJM197703102961019

Study Design of Immunotherapy of Ragweed Allergy

William Franklin, W. J. Metzger, R. Patterson, J. J. Pruzansky, C. R. Zeiss, Philip S. Norman, Lawrence M. Lichtenstein

School of Medicine

Research output: Contribution to journal › Letter

Abstract

To the Editor: The fine study of ragweed-allergy immunotherapy recently reported in the Journal¹ is of great interest to those who treat allergic patients. Although polymerized antigens may ultimately prove of great value in atopic disorders, the conclusion that “polymerized antigen represents an improved form of immunotherapy that is as effective as standard immunotherapy” is not supported by the data available. Polymerized antigen E was compared with monomer antigen E and not with crude ragweed extract. The authors assumed that antigen E had been shown to be safer than crude ragweed antigen and to possess equal clinical efficacy. This.

Original language	English (US)
Pages (from-to)	573-574
Number of pages	2
Journal	New England Journal of Medicine
Volume	296
Issue number	10
DOIs	https://doi.org/10.1056/NEJM197703102961019
State	Published - Mar 10 1977

Fingerprint

ASJC Scopus subject areas

Medicine(all)

Cite this

Franklin, W., Metzger, W. J., Patterson, R., Pruzansky, J. J., Zeiss, C. R., Norman, P. S., & Lichtenstein, L. M. (1977). Study Design of Immunotherapy of Ragweed Allergy. New England Journal of Medicine, 296(10), 573-574. https://doi.org/10.1056/NEJM197703102961019

@article{ef56f642c5ef4257906153d3c483eaa7,

title = "Study Design of Immunotherapy of Ragweed Allergy",

abstract = "To the Editor: The fine study of ragweed-allergy immunotherapy recently reported in the Journal1 is of great interest to those who treat allergic patients. Although polymerized antigens may ultimately prove of great value in atopic disorders, the conclusion that “polymerized antigen represents an improved form of immunotherapy that is as effective as standard immunotherapy” is not supported by the data available. Polymerized antigen E was compared with monomer antigen E and not with crude ragweed extract. The authors assumed that antigen E had been shown to be safer than crude ragweed antigen and to possess equal clinical efficacy. This.",

author = "William Franklin and Metzger, {W. J.} and R. Patterson and Pruzansky, {J. J.} and Zeiss, {C. R.} and Norman, {Philip S.} and Lichtenstein, {Lawrence M.}",

year = "1977",

month = mar

day = "10",

doi = "10.1056/NEJM197703102961019",

language = "English (US)",

volume = "296",

pages = "573--574",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "10",

}

TY - JOUR

T1 - Study Design of Immunotherapy of Ragweed Allergy

AU - Franklin, William

AU - Metzger, W. J.

AU - Patterson, R.

AU - Pruzansky, J. J.

AU - Zeiss, C. R.

AU - Norman, Philip S.

AU - Lichtenstein, Lawrence M.

PY - 1977/3/10

Y1 - 1977/3/10

N2 - To the Editor: The fine study of ragweed-allergy immunotherapy recently reported in the Journal1 is of great interest to those who treat allergic patients. Although polymerized antigens may ultimately prove of great value in atopic disorders, the conclusion that “polymerized antigen represents an improved form of immunotherapy that is as effective as standard immunotherapy” is not supported by the data available. Polymerized antigen E was compared with monomer antigen E and not with crude ragweed extract. The authors assumed that antigen E had been shown to be safer than crude ragweed antigen and to possess equal clinical efficacy. This.

AB - To the Editor: The fine study of ragweed-allergy immunotherapy recently reported in the Journal1 is of great interest to those who treat allergic patients. Although polymerized antigens may ultimately prove of great value in atopic disorders, the conclusion that “polymerized antigen represents an improved form of immunotherapy that is as effective as standard immunotherapy” is not supported by the data available. Polymerized antigen E was compared with monomer antigen E and not with crude ragweed extract. The authors assumed that antigen E had been shown to be safer than crude ragweed antigen and to possess equal clinical efficacy. This.

UR - http://www.scopus.com/inward/record.url?scp=0017771137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017771137&partnerID=8YFLogxK

U2 - 10.1056/NEJM197703102961019

DO - 10.1056/NEJM197703102961019

M3 - Letter

C2 - 618362

AN - SCOPUS:0017771137

VL - 296

SP - 573

EP - 574

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 10

ER -

Access to Document

10.1056/NEJM197703102961019